Trials / Completed
CompletedNCT04912297
Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10
Persistence of Humoral Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With the 10-valent Pneumococcal Conjugate Vaccine in Finland
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 186 (actual)
- Sponsor
- Finnish Institute for Health and Welfare · Other Government
- Sex
- All
- Age
- 13 Months – 3 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study are to assess the persistence of immunity against vaccine serotypes (VSTs) and vaccine-related serotypes in PCV10 vaccinated children in Finland.
Detailed description
The primary objective is to evaluate the long-term persistence of humoral immunity to vaccine-related pneumococcal serotypes after vaccination with PCV10.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | 10-valent pneumococcal conjugate vaccine, PCV10 | 10-valent pneumococcal conjugate vaccine, PCV10 |
Timeline
- Start date
- 2009-11-12
- Primary completion
- 2013-05-07
- Completion
- 2013-05-07
- First posted
- 2021-06-03
- Last updated
- 2021-08-11
- Results posted
- 2021-08-10
Locations
1 site across 1 country: Finland
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04912297. Inclusion in this directory is not an endorsement.